Taken together, SET played a positive role in regulating ovarian androgen biosynthesis by enhancing transcription of CYP17 and HSD3B2, which may participate in hyperandrogenism of PCOS. This evidence concerns the gene HSD3B2 and polycystic ovary syndrome.